Loading
Latest filing published 11 Jan 2023 for Imago BioSciences, Inc., €5.0M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jennifer Peppe in Imago BioSciences, Inc. We count 34 filings; the first trade dates from 12 January 2022 and the latest from 11 January 2023.
On the market, this insider has only sold: 9 sales, €9.1M in total. The rest of the record consists of 24 option exercises.
On 11 January 2023 came the latest disclosure, a transaction for €5.0M in Imago BioSciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations